Skip to content

Comparison Of Posterolateral and direct Anterior approach in uncemented total hip arthroplasty: treatment outcome and cost-effectiveness

Comparison Of Posterolateral and direct Anterior approach in uncemented total hip arthroplasty: treatment outcome and cost-effectiveness - COPA study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55723
Enrollment
120
Registered
2015-01-30
Start date
2015-08-04
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degeneration osteoarthritis

Interventions

The intervention studied in the proposed project is the direct anterior approach (DAA) for total hip replacement surgery. The DAA is compared to the more standard used posterolateral approach (PLA).

Sponsors

Noordwest Ziekenhuisgroep
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Willing and able to participate in the study protocol; • Age between 18 and 80 years • ASA Physical Status I, II and III • Diagnosed with osteoarthritis of the hip • Subjects for who it is decided that they will undergo an uncemented THA at Northwest Clinics Alkmaar

Exclusion criteria

Exclusion criteria: • Patients with previous surgery to the ipsilateral or controlateral hip; • Patients with posttraumatic changes of the pelvis or femur; • Patients with inflammatory arthropathies; • Patients diagnosed with osteoporosis • Patients diagnosed with rheumatoid arthritis • Patients who suffer from insulin dependant diabetes • Patients who lack understanding of the Dutch language • Patients who are treated for or diagnosed with neurological or muscle disorders which make assessment of pain and gait not possible

Design outcomes

Primary

MeasureTime frame
Functional outcome parameters Disability, functioning during daily living, recreational activities and sports (Hip dysfunction and Osteoarthritis Outcome Score) will be assessed preoperatively and at 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery.

Secondary

MeasureTime frame
Clinical outcome parameters Perceived pain is assessed preoperatively and during the first 3 days after surgery (VAS pain). Length of hospital stay is registered. Quality of Life (EQ-5D), perceived pain and symptoms, and complications are assessed preoperatively and at 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery. Functional outcome parameters Quality of walking will be assessed preoperatively and at 1 year after surgery during a timed up and go test and a two times 50m walk using inertial sensors. Surgical outcome parameters Operation time, blood loss, and other relevant parameters in relation to the surgical procedures are registered. The cup and stem positioning are assessed using standard radiography in the first (hospital) days after surgery and at 1 year after surgery. A small subgroup of patients will undergo a CT or MRI scan. Cost-effectiveness Productivity costs, direct medical costs (costs of additional radiography, medical consumption) are assessed using questionnaires at 0, 3, 6, 9 and 12 months after surgery.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026